Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

DME Innovations, Inc. (doing business as UpLyft, Inc.) is a company headquartered in San Diego, CA. The firm develops wheelchairs. It was founded in 2016 by Anton Keats Simson. Craig H. Misrach has been the CEO since 2018.\nThe company says this about itself: UpLyft addresses the critical need for an innovative method to empower people with mobility limitations to safely and efficiently self-transfer from bed to wheelchair, and vice versa. For consumers at home, UpLyft restores independence to people with mobility challenges, improving their quality of life. In institutional settings, UpLyft protects healthcare workers from encountering patient lifting injuries, avoiding costly workers compensation claims.

The Kobayashi Pharmaceutical Group provides a variety of products in fields such as pharmaceuticals, fragrances, dietary supplements and daily necessities. Providing products in these diverse fields is a business activity based on the broader management philosophy of “Providing Great Pleasure to People and Society” regardless of the current business domain. The current management philosophy was newly created in April 1999 by adding the meanings of “creation and innovation” and “Something New Something Different”, which are one of the characteristics of the Kobayashi Pharmaceutical Group, to the conventional management philosophy. is. The Kobayashi Pharmaceutical Group believes that pursuing the provision of “Pleasure” for people and society in this management philosophy is the significance of the Kobayashi Pharmaceutical Group.

SenCere Medical is working to prevent the occurrence of pressure ulcers by providing innovative medical devices.\nSenCere's product development is based on its own clinical research in which the physiological mechanisms of pressure ulcer formation are studied, and the results are used to develop a relief alarm, currently under development. SenCere has completed development of their product, SitSafe. First field test are performed during 2011. SenCere's relief alarm aims to help patients and caregivers prevent the occurrence of pressure ulcers.\nThe company SenCere was founded in 2008 after having been started as a business development project at the Göteborg International Bioscience Business School in 2007. The business was based on an idea and a dissertation made at the then Department of Biomedicine and Surgery at Hälsouniversitetet (the University of Health), and the collaboration between Göteborg and Linköping that emerged. SenCere has evolved from a research project to a company within the Sahlgrenska Science Park incubator.\nSenCere enters an exciting phase where the company is commencing pilot tests of their prototype with potential customers. The first commercial sale is expected to occur within one year to existing contacts in the health care system.

R.L.E. Corp. is an American private company focused on commercial economic, sociological, and educational research.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Boston Scientific Neuromodulation Corp. offers implantable pain management devices for neuromodulation. The company is headquartered in Marlborough, MA.

Ajinomoto Co. is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto Co. has contributed to food culture and human health through wide-ranging application of amino acid technologies. Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability. Founded in 1909 and now operating in 26 countries, Ajinomoto Co. had net sales of JPY 1,197.3 billion (USD 15.1 billion) in fiscal 2011. The Ajinomoto Group Standards of Business Conduct (hereinafter the "Standards of Conduct") describe the conduct that every member of the Ajinomoto Group must understand and practice every day in order to implement the Ajinomoto Group Philosophy in accordance with the Ajinomoto Group Way. The Standards of Conduct also represent the commitments made to all stakeholders by Ajinomoto Group companies. Ajinomoto aim to be "a group of companies that contributes to human health globally" by continually creating unique value to benefit customers. To become a global group of food companies centered on the world's No. 1 seasoning business. To become a global group of aminoscience companies that contributes to humankind with the world's No. 1 amino acid technology. To become a group of health-promoting companies with a scientific approach to good taste and health.

ETRI is the largest government funded research institute in Korea, which strives to advance science by means of formulating innovative ideas; developing new techniques; and training professional individuals in the area of information telecommunications to ultimately enhance social and economical aspects of the modern society.

Maxon Corp. manufactures industrial combustion systems, equipment, and components to the industrial heating industry. The firm’s products include gas burners, gas valves, oil burners, shut off valves, combustion systems, flow control, and low NOx burners. It has locations in Belgium, China, India, Singapore, and the United States of America. The company was founded in 1916 and is headquartered in Muncie, IN.

MEDA Pharma is a company that provides healthcare services to people of high quality with safety. A medium-sized pharmaceutical company, Madaus GmbH belongs to the worldwide operating Meda Group. They manufacture pharmaceuticals as well as scientifically based health products such as medical devices, cosmetics, and dietary supplements. Its mission was to set new standards for health care, give 7 billion people access to high-quality medicine, and carry out research to address unmet healthcare needs.

Weihai Jiaxiao Food Square Co., Ltd., established on 2006-02-17, Business scope includes food sales;Fresh aquatic products,Office Supplies,Sales of daily necessities;Technical consulting in the field of food technology,Technical Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

ONO Pharmaceutical is focused on the production, purchase, and sale of pharmaceuticals and diagnostic reagents on prescription pharmaceuticals. The company focuses on drug discovery leads that are high in certainty and globally competitive. The company was started in 1717 in Dosho-machi, Osaka. Throughout its 300-year history, ONO has dedicated itself to developing innovative and breakthrough pharmaceutical products.

Guangzhou Tongbaibai Biotechnology Co., Ltd., established on 2016-07-26, Business scope includes biotechnology development services;Biotechnology Consulting,communication service;Commodity wholesale trade(Except for licensed and approved products);Commodity retail trade(Except for licensed and approved products);